Since the 1990s, the number of specialty drugs available on the market has increased exponentially. Employer-sponsored health plans have seen a rise in pharmacy expense due to the increasing availability and costs of these medications. As a result, employers are seeking ways to curb specialty Rx spend.
Download this white paper to learn:
- Approaches to reducing spending
- Compliance and regulatory consequences of those approaches
- Possible solutions and considerations